Patents by Inventor Laman Lynn Alani

Laman Lynn Alani has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Controlled release formulations of levodopa and uses thereof
    Patent number: 9463246
    Abstract: The current invention provides a controlled release oral solid formulation of levodopa comprising levodopa, a decarboxylase inhibitor, and a carboxylic acid. Also provided by this invention is multiparticulate, controlled release oral solid formulations of levodopa comprising: i) a controlled release component comprising a mixture of levodopa, a decarboxylase inhibitor and a rate controlling excipient; ii) a carboxylic acid component; and iii) an immediate release component comprising a mixture of levodopa and a decarboxylase inhibitor.
    Type: Grant
    Filed: September 18, 2013
    Date of Patent: October 11, 2016
    Assignee: Impax Laboratories, Inc.
    Inventors: Ann Hsu, Jim H. Kou, Laman Lynn Alani
  • Controlled release formulations of levodopa and uses thereof
    Patent number: 9089608
    Abstract: The current invention provides a controlled release oral solid formulation of levodopa comprising levodopa, a decarboxylase inhibitor, and a carboxylic acid. Also provided by this invention is multiparticulate, controlled release oral solid formulations of levodopa comprising: i) a controlled release component comprising a mixture of levodopa, a decarboxylase inhibitor and a rate controlling excipient; ii) a carboxylic acid component; and iii) an immediate release component comprising a mixture of levodopa and a decarboxylase inhibitor.
    Type: Grant
    Filed: September 18, 2013
    Date of Patent: July 28, 2015
    Assignee: Impax Laboratories, Inc.
    Inventors: Ann Hsu, Jim H. Kou, Laman Lynn Alani
  • Controlled release formulations of levodopa and uses thereof
    Patent number: 9089607
    Abstract: The current invention provides a controlled release oral solid formulation of levodopa comprising levodopa, a decarboxylase inhibitor, and a carboxylic acid. Also provided by this invention is multiparticulate, controlled release oral solid formulations of levodopa comprising: i) a controlled release component comprising a mixture of levodopa, a decarboxylase inhibitor and a rate controlling excipient; ii) a carboxylic acid component; and iii) an immediate release component comprising a mixture of levodopa and a decarboxylase inhibitor.
    Type: Grant
    Filed: May 22, 2013
    Date of Patent: July 28, 2015
    Assignee: Impax Laboratories, Inc.
    Inventors: Ann Hsu, Jim H. Kou, Laman Lynn Alani
  • CONTROLLED RELEASE FORMULATIONS OF LEVODOPA AND USES THEREOF
    Publication number: 20140024718
    Abstract: The current invention provides a controlled release oral solid formulation of levodopa comprising levodopa, a decarboxylase inhibitor, and a carboxylic acid. Also provided by this invention is multiparticulate, controlled release oral solid formulations of levodopa comprising: i) a controlled release component comprising a mixture of levodopa, a decarboxylase inhibitor and a rate controlling excipient; ii) a carboxylic acid component; and iii) an immediate release component comprising a mixture of levodopa and a decarboxylase inhibitor.
    Type: Application
    Filed: September 18, 2013
    Publication date: January 23, 2014
    Inventors: Ann Hsu, Jim H. Kou, Laman Lynn Alani
  • CONTROLLED RELEASE FORMULATIONS OF LEVODOPA AND USES THEREOF
    Publication number: 20140018425
    Abstract: The current invention provides a controlled release oral solid formulation of levodopa comprising levodopa, a decarboxylase inhibitor, and a carboxylic acid. Also provided by this invention is multiparticulate, controlled release oral solid formulations of levodopa comprising: i) a controlled release component comprising a mixture of levodopa, a decarboxylase inhibitor and a rate controlling excipient; ii) a carboxylic acid component; and iii) an immediate release component comprising a mixture of levodopa and a decarboxylase inhibitor.
    Type: Application
    Filed: September 18, 2013
    Publication date: January 16, 2014
    Inventors: Ann Hsu, Jim H. Kou, Laman Lynn Alani
  • Controlled release formulations of levodopa and uses thereof
    Patent number: 8557283
    Abstract: The current invention provides a controlled release oral solid formulation of levodopa comprising levodopa, a decarboxylase inhibitor, and a carboxylic acid. Also provided by this invention is multiparticulate, controlled release oral solid formulations of levodopa comprising: i) a controlled release component comprising a mixture of levodopa, a decarboxylase inhibitor and a rate controlling excipient; ii) a carboxylic acid component; and iii) an immediate release component comprising a mixture of levodopa and a decarboxylase inhibitor.
    Type: Grant
    Filed: December 11, 2012
    Date of Patent: October 15, 2013
    Assignee: Impax Laboratories, Inc.
    Inventors: Ann Hsu, Jim H. Kou, Laman Lynn Alani
  • CONTROLLED RELEASE FORMULATIONS OF LEVODOPA AND USES THEREOF
    Publication number: 20130259932
    Abstract: The current invention provides a controlled release oral solid formulation of levodopa comprising levodopa, a decarboxylase inhibitor, and a carboxylic acid. Also provided by this invention is multiparticulate, controlled release oral solid formulations of levodopa comprising: i) a controlled release component comprising a mixture of levodopa, a decarboxylase inhibitor and a rate controlling excipient; ii) a carboxylic acid component; and iii) an immediate release component comprising a mixture of levodopa and a decarboxylase inhibitor.
    Type: Application
    Filed: May 22, 2013
    Publication date: October 3, 2013
    Inventors: Ann Hsu, Jim H. Kou, Laman Lynn Alani
  • CONTROLLED RELEASE FORMULATIONS OF LEVODOPA AND USES THEREOF
    Publication number: 20130102676
    Abstract: The current invention provides a controlled release oral solid formulation of levodopa comprising levodopa, a decarboxylase inhibitor, and a carboxylic acid. Also provided by this invention is multiparticulate, controlled release oral solid formulations of levodopa comprising: i) a controlled release component comprising a mixture of levodopa, a decarboxylase inhibitor and a rate controlling excipient; ii) a carboxylic acid component; and iii) an immediate release component comprising a mixture of levodopa and a decarboxylase inhibitor.
    Type: Application
    Filed: December 11, 2012
    Publication date: April 25, 2013
    Inventors: Ann Hsu, Jim H. Kou, Laman Lynn Alani
  • Gastroretentive Solid Oral Dosage Forms with Swellable Hydrophilic Polymer
    Publication number: 20130064896
    Abstract: The disclosure provides multiparticulate systems that give release of active agents with a narrow window of absorption such that there is bioavailability to a patient. The disclosure provides a composition comprising microparticulates comprising a swellable hydrophilic polymer and an active agent, wherein the swellable hydrophilic polymer is substantially non-crosslinked intramolecularly, and the size of the microparticulates is about 500 ?m or less.
    Type: Application
    Filed: December 28, 2010
    Publication date: March 14, 2013
    Inventors: Laman Lynn Alani, Jim H. Kou, Shook-Fong Chin, Guangbin Ding, Natasha G. Masand